Recombinant <i>Ehrlichia canis</i> GP19 Protein as a Promising Vaccine Prototype Providing a Protective Immune Response in a Mouse Model

Recombinant <i>Ehrlichia canis</i> GP19 Protein as a Promising Vaccine Prototype Providing a Protective Immune Response in a Mouse Model

The intracellular bacterium <i>Ehrlichia canis</i> is the causative pathogen of canine monocytic ehrlichiosis (CME) in dogs. Despite its veterinary and medical importance, there is currently no available vaccine against this pathogen. In this study, the recombinant GP19 (rGP19) was produ...

Full description

Bibliographic Details
Main Authors: Boondarika Nambooppha, Amarin Rittipornlertrak, Anucha Muenthaisong, Pongpisid Koonyosying, Paweena Chomjit, Kanokwan Sangkakam, Sahatchai Tangtrongsup, Saruda Tiwananthagorn, Nattawooti Sthitmatee
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Veterinary Sciences
Subjects:
CME
<i>Ehrlichia canis</i>
GP19
mice
recombinant protein
vaccine prototype
Online Access:https://www.mdpi.com/2306-7381/9/8/386

Internet

https://www.mdpi.com/2306-7381/9/8/386

Similar Items